Open, randomized study comparing the efficacy of retreatment with etanercept or rituximab, after failure of efficacy of rituximab in patients with active rheumatoid arthritis.

Trial Profile

Open, randomized study comparing the efficacy of retreatment with etanercept or rituximab, after failure of efficacy of rituximab in patients with active rheumatoid arthritis.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 03 Jul 2012

At a glance

  • Drugs Etanercept (Primary) ; Methotrexate; Rituximab
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Mar 2012 Planned End Date changed to 31 Mar 2012.
    • 02 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top